Senores PharmaceuticalsNSE:SENORES +1.77%18 Interest Coverage is 4.51 as of Mar. 2026, which is 21% above its 10-year median of 3.73. GuruFocus rates NSE:SENORES with a GF Score™ of 18/100. The stock has 7 warning signs investors should review. Among 686 Drug Manufacturers companies, Senores Pharmaceuticals ranks worse than 65.89% on this metric.
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's
Operating Income
by its Interest Expense. Senores Pharmaceuticals's
Operating Income
for the
three
months ended in Mar. 2026 was ₹382 Mil. Senores Pharmaceuticals's Interest Expense for the
three
months ended in Mar. 2026 was ₹-85 Mil.
Senores Pharmaceuticals's interest coverage for the quarter that ended in Mar. 2026 was 4.51.
The higher the ratio, the stronger the company's financial strength is.
The historical rank and industry rank for Senores Pharmaceuticals's Interest Coverage or its related term are showing as below:
NSE:SENORES'
s Interest Coverage Range Over the Past 10 Years
Min: 2.45 Med: 3.73 Max: 6.15
Current: 6.15
NSE:SENORES's Interest Coverage is ranked worse than 65.89% of 686
companies
in the Drug Manufacturers industry
Industry Median: 12.725
vs NSE:SENORES: 6.15
Ben Graham requires that a company has a minimum interest coverage of 5 with the companies he invested. If the interest coverage is less than 2, the company is burdened by debt. Any business slow or recession may drag the company into a situation where it cannot pay the interest on its debt.
Interest Coverage is an important factor when GuruFocus ranks a company's overage Financial Strength .
Senores Pharmaceuticals Interest Coverage Related Terms
Senores Pharmaceuticals Interest Coverage Historical Data
* Premium members only.
The historical data trend for Senores Pharmaceuticals's Interest Coverage can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Note: For Interest Coverage, "No debt" indicates no long-term debt. An indication of "No Debt" does not necessarily mean that the company has no long-term debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.
NSE:SENORES vs LLY, JNJ, ABBV: Interest Coverage Comparison
For the Drug Manufacturers - General subindustry, Senores Pharmaceuticals's Interest Coverage, along with its competitors' market caps and Interest Coverage data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Senores Pharmaceuticals Interest Coverage vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Senores Pharmaceuticals's Interest Coverage distribution charts can be found below:
* The bar in red indicates where Senores Pharmaceuticals's Interest Coverage falls into.
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Senores Pharmaceuticals (NSE:SENORES) has a Interest Coverage of 4.51 as of Mar. 2026. Interest Coverage measures a company's capability to pay interest expenses on its debt. View historical data on Senores Pharmaceuticals and its competitors. This is 21% above median its historical median of 3.73. Over the past decade, Senores Pharmaceuticals' Interest Coverage has ranged from 2.45 to 6.15. According to the industry distribution chart, Senores Pharmaceuticals ranks #452 out of 686 companies in the Drug Manufacturers industry, placing it in the top 65.9%.
Is Senores Pharmaceuticals' Interest Coverage too high?
Senores Pharmaceuticals' current Interest Coverage of 4.51 is 21% above median its 10-year median of 3.73. Over the past 10 years, this metric has ranged from a low of 2.45 to a high of 6.15. The Drug Manufacturers industry median Interest Coverage is 12.73. Senores Pharmaceuticals' value of 4.51 is 64.6% below this industry median. Based on the distribution chart, Senores Pharmaceuticals ranks #452 out of 686 companies in the Drug Manufacturers industry, which is below the industry midpoint. Overall, Senores Pharmaceuticals has a GF Score™ of 18/100, reflecting its overall financial health beyond just this single metric.
How does Senores Pharmaceuticals' Interest Coverage compare to LLY and JNJ?
According to the Drug Manufacturers industry distribution chart, Senores Pharmaceuticals ranks #452 out of 686 companies for Interest Coverage. This places Senores Pharmaceuticals in the lower half of its industry. The industry median Interest Coverage is 12.73. Senores Pharmaceuticals' value of 4.51 is 64.6% below this benchmark. Historically, Senores Pharmaceuticals' own Interest Coverage has ranged from 2.45 to 6.15 over the past decade. While the company's 10-year median is 3.73 vs. the industry median of 12.73, Senores Pharmaceuticals has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Interest Coverage for a Drug Manufacturers company?
The median Interest Coverage among Drug Manufacturers companies is 12.73, based on 686 companies in the industry. Companies in the top quartile (top 25%) have a Interest Coverage significantly above this median, while those in the bottom quartile fall well below. However, Interest Coverage should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Senores Pharmaceuticals's current Interest Coverage of 4.51 is 64.6% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Interest Coverage mean?
A high Interest Coverage can signal that a stock is expensive relative to its fundamentals. Interest Coverage measures a company's capability to pay interest expenses on its debt. View historical data on Senores Pharmaceuticals and its competitors. For the Drug Manufacturers industry, the median Interest Coverage is 12.73 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Senores Pharmaceuticals's current Interest Coverage is 4.51, which is 21% above median its own 10-year median of 3.73. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Senores Pharmaceuticals stock overvalued right now?
Senores Pharmaceuticals (NSE:SENORES) has a current Interest Coverage of 4.51. The current Interest Coverage is 4.51, which is 21% above median its 10-year median of 3.73 and 64.6% below the Drug Manufacturers industry median of 12.73. Senores Pharmaceuticals' overall GF Score™ is 18/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Interest Coverage calculated?
Interest Coverage is calculated from a company's financial statements. For Senores Pharmaceuticals (NSE:SENORES), the current Interest Coverage is 4.51 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Senores Pharmaceuticals Ltd is a research-driven pharmaceutical company engaged in developing and manufacturing a wide range of pharmaceutical products predominantly for the Regulated Markets of the USA, Canada and United Kingdom across various therapeutic areas and dosage forms, with a presence in Emerging Markets. Its strength lies in identifying, developing and manufacturing a diverse range of specialty, underpenetrated and complex pharmaceutical products establishing the company as a preferred partner to certain customers. Through data analytics, research, market assessment and experienced management, It strategically identifies commercially underpenetrated molecules to launch products in the Regulated and Emerging Markets.
18GF Score
Get the complete analysis for NSE:SENORES
Interest Coverage is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:SENORES has been successfully added to your 
